 Preventive therapy first gastrointestinal bleeding patients cirrhosis results controlled trial comparing propranolol sclerotherapy placebo Propranolol endoscopic sclerosis esophageal varices approaches prophylaxis first gastrointestinal hemorrhage cirrhotic patient twenty-six cirrhotic patients esophageal varices histories trial regardless gravity cirrhosis size esophageal varices Patients hepatocarcinomas cancers impossible follow-up previous treatment portal hypertension contraindication beta-blockers randomization patients propranolol dose heart rate patients intravariceal extravariceal injections Polidocanol control patients vitamin placebo patients intervals entry trial groups comparable terms clinical biological parameters size esophageal varices grade II III Child-Pugh classification origin cirrhosis alcoholic cases Twenty-four patients propranolol group endoscopic sclerosis esophageal varices group placebo group Actuarial estimates Kaplan-Meier time onset first bleeding differences significant propranolol placebo propranolol sclerotherapy sclerotherapy placebo